BEAM — Beam Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00
- $2.11bn
- $1.11bn
- $377.71m
- 59
- 23
- 27
- 29
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 91.8 | 300 | 966 | 1,078 | 1,190 |
Net Total Accounts Receivable | |||||
Net Total Receivables | — | — | 300 | 0 | — |
Prepaid Expenses | |||||
Total Current Assets | 94.5 | 308 | 1,273 | 1,093 | 1,211 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 43.2 | 125 | 187 | 234 | 238 |
Other Long Term Assets | |||||
Total Assets | 156 | 452 | 1,474 | 1,342 | 1,460 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 29.1 | 102 | 213 | 224 | 206 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 55.2 | 206 | 648 | 608 | 478 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 101 | 246 | 827 | 733 | 981 |
Total Liabilities & Shareholders' Equity | 156 | 452 | 1,474 | 1,342 | 1,460 |
Total Common Shares Outstanding |